Eko honored for achievements in AI-powered solutions to improve cardiac care
BERKELEY, Calif.-- March 3, 2020 -- Eko today announced that it has been named to CB Insights’ fourth annual AI 100 ranking, showcasing the100 most promising private artificial intelligence companies in the world.
“Eko has achieved numerous milestones over the past year, including partnerships with preeminent healthcare institutions, breakthrough FDA status on our low ejection fraction screening algorithm, and most recently, FDA clearance of our atrial fibrillation and heart murmur detection algorithms, all of which further our mission to enable healthcare clinicians to better detect heart disease during routine office visits,” said Connor Landgraf, Co-Founder and CEO of Eko. “Our team is proud to be recognized by CB Insights as one of the most innovative artificial intelligence startups and look forward to continuing to bring AI-powered cardiac screening to the front lines of care.”
Through an evidence-based approach, the CB Insights research team selected the AI 100 from nearly 5,000 companies based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength and tech novelty. The Mosaic Score, based on CB Insights’ algorithm, measures the overall health and growth potential of private companies to help predict a company’s momentum.
“It's been remarkable to see the success of the companies named to the Artificial Intelligence 100 over the last four years. The 2019 AI100 saw 48 companies go on to raise $4.9B of additional financing and nine got acquired,” said CB Insights CEO Anand Sanwal. “It has been gratifying to see that CB Insights' data-driven approach to identifying the top AI companies using patents, customer traction, investor quality, market sizing and more has become so effective at picking the AI winners of tomorrow. We look forward to seeing what the 2020 AI 100 companies will accomplish over the course of this year and beyond."
In addition to disrupting core sectors including healthcare, retail and finance, the 2020 AI 100 companies are revamping the broader enterprise tech stack. These companies span the globe, from the US, UK,China, Chile, and South Africa, and are supported by more than 600 investors.
Quick facts on the 2020 AI 100:
- As of the end of February 2020, these 100 emerging private companies have raised over $7.4B in funding across 300+ deals from 600+ unique investors.
- There are 10 unicorns (companies valued over $1B) in this year’s AI 100 cohort.
- The list spans across various industries, including healthcare, retail & warehouse, and finance & insurance.
- 13 countries, such as China, Sweden, and Japan, are represented on the ranking. The majority of startups (65%) are based in the United States.
About CB Insights
CB Insights helps the world’s leading companies accelerate their digital strategy and transformation efforts with data, not opinion. Our Emerging Tech InsightsPlatform provides companies with actionable insights and tools to discover and manage their response to emerging technology and startups. To learn more, please visit www.cbinsights.com.
Eko is driving the next evolution in cardiac care by creating digital health solutions that enable doctors, nurses and entire health systems to change how we care for the heart. Eko brings together advanced stethoscopes, patient and provider software, and AI-powered analysis—elevating the way clinicians detect and monitor cardiovascular disease. Its FDA cleared platform is used by thousands of clinicians treating tens of millions of patients around the world. Eko is a privately-held company headquartered in Berkeley, California. For more information visit www.ekohealth.com.
+1 (781) 235-3060